Chris Baldwin,
Chief Commercial Officer
Dr Chris Baldwin joined Exopharm in November 2019, bringing a wide range of global commercial experience to the company.
Chris’ strategic focus and approach to management comes from his time at McKinsey and Company, where he served banking, pharmaceutical and NGO clients.
More recently, Chris was responsible for Haemonetics’ largest and most profitable business unit across Asia Pacific, with P&L responsibilities from Taiwan to Pakistan. Previously responsible for all sales and marketing in Southeast Asia, Chris provided strategy leadership across Asia Pacific, including China.
Healthcare became the focus of Chris’ career at New York Blood Center, where he was Executive Director for 8 years and responsible for the blood supply across the greater New York metropolitan area.
Chris received his PhD in Chemical Engineering from the University of Cambridge, while matriculated at Trinity College.
|
|
|
